Tom 14, Nr 4 (2019)
Artykuł przeglądowy
Opublikowany online: 2019-09-06
Wyświetlenia strony
502
Wyświetlenia/pobrania artykułu
3237
Rola diagnostyki kardiologicznej u pacjentów z udarem kryptogennym — aktualny stan wiedzy
DOI: 10.5603/FC.2019.0093
Folia Cardiologica 2019;14(4):349-355.
Streszczenie
Udar kryptogenny to udar mózgu o nieznanej etiologii. Ponad 2/3 udarów kryptogennych ma podłoże zatorowe, głównie kardiogenne.
Dlatego tak ważne są obrazowa diagnostyka kardiologiczna oraz diagnostyka zaburzeń rytmu serca, zwłaszcza migotania przedsionków. U osób z implantowanymi urządzeniami wszczepialnymi należy rutynowo wykorzystywać zapisy wewnątrzsercowego elektrokardiogramu w pamięci urządzenia, w poszukiwaniu tak zwanych szybkich rytmów przedsionkowych. Udoskonalenie narzędzi diagnostycznych oraz postępy w wykrywaniu migotania przedsionków sprawiają, że coraz mniej udarów mózgu pozostaje bez ustalonej przyczyny, co w wielu przypadkach pozwala na odpowiednio wczesne wdrożenie profilaktyki wtórnej.
Słowa kluczowe: udar kryptogennyudar zatorowy z nieokreślonego źródładiagnostyka kardiologicznaprzetrwały otwór owalnymigotanie przedsionków
Referencje
- O'Donnell MJ, Xavier D, Liu L, et al. INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010; 376(9735): 112–123.
- Ay H, Furie KL, Singhal A, et al. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005; 58(5): 688–697.
- Kolominsky-Rabas P, Weber M, Gefeller O, et al. Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria. Stroke. 2001; 32(12): 2735–2740.
- Hart RG, Diener HC, Coutts SB, et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4): 429–438.
- Arboix A, Alio J, Arboix A, et al. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010; 6(3): 150–161.
- Hart RG, Diener HC, Coutts SB, et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4): 429–438.
- January C, Wann L, Alpert J, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary. Circulation. 2014; 130(23): 2071–2104.
- Sposato LA, Cipriano LE, Saposnik G, et al. Diagnosis of atrial fibrillation after stroke and transient ischemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(4): 377–387.
- Powers WJ, Rabinstein AA, Ackerson T T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018; 49((3): e46–e110.
- Kamel H, Hunter M, Moon Y, et al. Electrocardiographic Left Atrial Abnormality and Risk of Stroke. Stroke. 2015; 46(11): 3208–3212.
- Kamel H, Okin PM, Longstreth WT, et al. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol. 2015; 11(3): 323–331.
- Dussault C, Toeg H, Nathan M, et al. Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2015; 8(2): 263–269.
- Ricci B, Chang AD, Hemendinger M, et al. A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source. J Stroke Cerebrovasc Dis. 2018; 27(6): 1692–1696.
- Montalvo M, Tadi P, Merkler A, et al. PR Interval Prolongation and Cryptogenic Stroke: A Multicenter Retrospective Study. J Stroke Cerebrovasc Dis. 2017; 26(10): 2416–2420.
- Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009; 373(9665): 739–745.
- Lau JK, Lowres N, Neubeck L, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013; 165(1): 193–194.
- Sanna T, Diener HC, Passman R, et al. Cryptogenic Stroke and Underlying Atrial Fibrillation. New England Journal of Medicine. 2014; 370(26): 2478–2486.
- Healey JS, Connolly SJ, Gold MR, et al. ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366(2): 120–129.
- Erküner Ö, Rienstra M, Van Gelder IC, et al. Stroke risk in patients with device-detected atrial high-rate episodes. Neth Heart J. 2018; 26(4): 177–181.
- Van Gelder IC, Healey JS, Crijns HJ, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017; 38(17): 1339–1344.
- William JP, Kent DM, Bulsara KR, et al. American Heart Association Stroke Council. Effect of dysphagia screening strategies on clinical outcomes after stroke: a systematic review for the 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018; 49(3): e123–e128.
- McGrath ER, Paikin JS, Motlagh B, et al. Transesophageal echocardiography in patients with cryptogenic ischemic stroke: a systematic review. Am Heart J. 2014; 168(5): 706–712.
- Longobardo L, Zito C, Carerj S, et al. Role of Echocardiography in Assessment of Cardioembolic Sources: a Strong Diagnostic Resource in Patients with Ischemic Stroke. Curr Cardiol Rep. 2018; 20(12): 136.
- Hilberath JN, Oakes DA, Shernan SK, et al. Safety of transesophageal echocardiography. J Am Soc Echocardiogr. 2010; 23(11): 1115–27; quiz 1220.
- Mattle HP, Meier B, Nedeltchev K. Prevention of stroke in patients with patent foramen ovale. Int J Stroke. 2010; 5(2): 92–102.
- Cotter PE, Martin PJ, Belham M. Patent foramen ovale are more common than previously thought in young patients with strokes. Cerebrovasc Dis. 2010; 29(Suppl. 2): 609.
- Monte I, Grasso S, Licciardi S, et al. Head-to-head comparison of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale. Eur J Echocardiogr. 2010; 11(3): 245–249.
- Fan S, Nagai T, Luo H, et al. Superiority of the combination of blood and agitated saline for routine contrast enhancement. J Am Soc Echocardiogr. 1999; 12(2): 94–98.
- Schuchlenz HW, Weihs W, Horner S, et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med. 2000; 109(6): 456–462.
- Messé SR, Silverman IE, Kizer JR, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004; 62(7): 1042–1050.
- Prefasi D, Martínez-Sánchez P, Fuentes B, et al. The utility of the RoPE score in cryptogenic stroke patients ≤50 years in predicting a stroke-related patent foramen ovale. Int J Stroke. 2016; 11(1): NP7–NP8.
- Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013; 81(7): 619–625.
- Lima J, Desai M. Cardiovascular magnetic resonance imaging: Current and emerging applications. Journal of the American College of Cardiology. 2004; 44(6): 1164–1171.
- Baher A, Mowla A, Kodali S, et al. Cardiac MRI improves identification of etiology of acute ischemic stroke. Cerebrovasc Dis. 2014; 37(4): 277–284.
- Światkiewicz I. „Zastosowanie echokardiografii w diagnostyce i terapii zatorowości sercowopochodnej –wybrane aspekty w świetle zaleceń Europejskiego Towarzystwa Echokardiograficznego”. Folia Cardiologica Excerpta. 2010; 5(6): 339–52.
